Is N4 Pharma PLC halal to invest in?

As of September 2026, N4 Pharma PLC ONZ.AQ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is N4 Pharma PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes N4 Pharma PLC using these criteria to determine its compliance status.

Can Muslims buy shares of N4 Pharma PLC?

Muslim investors may consider investing in N4 Pharma PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is N4 Pharma PLC classified as NOT HALAL?

Musaffa determines the Shariah status of N4 Pharma PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for N4 Pharma PLC updated?

The Shariah compliance status of N4 Pharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like N4 Pharma PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of N4 Pharma PLC?

You can check the latest Shariah compliance status of N4 Pharma PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Is N4 Pharma PLC Stock Halal?

Shariah Compliance Analysis of ONZ.AQ Stock

United Kingdom Health Care Nano Cap

No. As of September 2026, N4 Pharma PLC (ONZ.AQ) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. N4 Pharma PLC does not pass Musaffa's business and financial screening criteria.

N4 Pharma Plc is a pharmaceutical company, which engages in the reformulation of existing drugs and vaccines. The company is headquartered in Derby, Derbyshire and currently employs 4 full-time employees. The company went IPO on 2005-06-07. The firm is engaged in developing Nuvec, its proprietary gene delivery system, to enable advanced therapies for cancer and other diseases. The firm is building out its preclinical dataset and working towards first-in-human clinical data to support licensing deals for its Nuvec platform with gene therapy partners. Its lead program, N4 101, is an oral anti-inflammatory product for inflammatory bowel disease (IBD) which serves as a proof-of-concept program showcasing all the benefits of the Nuvec platform. ECP105 is a siRNA therapy intended for injection into the ocular cavity and contains a proprietary siRNA sequence to silence the fibrotic gene responsible for fibrosis (MRTF-B), or scarring, which occurs post-surgery. LipTide is a patented lipid and peptide-based delivery system for nucleic acids that mimics a natural virus for targeted delivery of RNA into cells.

N4 Pharma PLC ONZ.AQ

ONZ.AQ Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, N4 Pharma PLC is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

N4 Pharma PLC (ONZ.AQ) Chart

Financial Metrics & Statements of N4 Pharma PLC (ONZ.AQ)

FAQ's for N4 Pharma PLC (ONZ.AQ)

As of September 2026, N4 Pharma PLC ONZ.AQ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes N4 Pharma PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in N4 Pharma PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of N4 Pharma PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of N4 Pharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of N4 Pharma PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Alternate Halal Stocks for N4 Pharma PLC (ONZ.AQ)

Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.

Name	Price	1D Change	Market Cap	Rating
Indivior PLC INDV.L	GBX1,238.00	0.80%	GBX145.13B	Unlock
Animalcare Group plc ANCR.L	GBX335.07	0.00%	GBX23.03B	Unlock
Celadon Pharmaceuticals PLC CEL.L	GBX13.40	0.00%	GBX913.47M	Unlock